Your provider may order this test before GLP-1 initiation if risk is elevated
The issues include whether federal law preempts failure-to-warn claims and whether existing evidence sufficiently links GLP-1 medications to gastroparesis and other gastrointestinal injuries
Cntl, control
Smaglo, Musher B, Vasileiou BL, Kuvalekar S, Watanabe M, Robertson A, Wang CS, Francois T, Ramos M, Hill CA, Buren LV, Fisher G, Armaghany WE, Sada T, Valdes YV, Grilley JF, Gee BJ, Heslop AP, Lulla HE, Leen PD, Ann M
Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia
PMid:37446334